Purdue receives $100M for Pluvicto royalties
The Purdue Research Foundation said Wednesday it has received more than $100 million from Owl Rock in New York for a portion of its royalty interest in the prostate cancer drug Pluvicto. Purdue plans to use the funding to further support research at the university.... Read More
